Guardian Pharmacy Services Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 1 out of 30 in the Food & Drug Retailing industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 38.50.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Guardian Pharmacy Services Inc is 9.46, ranking 1 out of 30 in the Food & Drug Retailing industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 397.62M, representing a year-over-year increase of 17.44%, while its net profit experienced a year-over-year increase of 75.19%.
Key Metrics
The current valuation score of Guardian Pharmacy Services Inc is 8.33, ranking 10 out of 30 in the Food & Drug Retailing industry. Its current P/E ratio is 47.23, which is 8.84% below the recent high of 51.40 and 135.76% above the recent low of -16.89.
The current earnings forecast score of Guardian Pharmacy Services Inc is 9.00, ranking 1 out of 30 in the Food & Drug Retailing industry. The average price target is 34.50, with a high of 35.00 and a low of 32.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Guardian Pharmacy Services Inc is 9.49, ranking 1 out of 30 in the Food & Drug Retailing industry. Currently, the stock price is trading between the resistance level at 40.05 and the support level at 32.54, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Guardian Pharmacy Services Inc is 5.00, ranking 14 out of 30 in the Food & Drug Retailing industry. The latest institutional shareholding proportion is 59.61%, representing a quarter-over-quarter increase of 15.07%. The largest institutional shareholder is The Vanguard, holding a total of 1.35M shares, representing 3.72% of shares outstanding, with 44.24% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Guardian Pharmacy Services Inc is 6.17, ranking 14 out of 30 in the Food & Drug Retailing industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
